NCCN

NCCN Updates Clinical Practice Guideline for Breast Cancer
NCCN Updates Clinical Practice Guideline for Breast Cancer
03/15/2021
The National Comprehensive Cancer Network released an update to its clinical practice guideline for breast cancer.
The National Comprehensive Cancer Network released an update to its clinical practice guideline for breast cancer.
The National Comprehensive...
03/15/2021
Journal of Clinical Pathways
Conference Coverage
NCCN Guideline Adherence Associated With Improved Patient Outcomes in Anal Cancer
01/15/2021
01/15/2021
Journal of Clinical Pathways
Real-World Adherence to NCCN Guidelines in Advanced Classical Hodgkin Lymphoma
Videos
Real-World Adherence to NCCN Guidelines in Advanced Classical Hodgkin Lymphoma
01/14/2021
Christopher Yasenchak, MD, discusses real-world adherence to National Comprehensive Cancer Network (NCCN) Guidelines regarding PET/CT usage and reported Deuville scores in advanced stage classical Hodgkin lymphoma.
Christopher Yasenchak, MD, discusses real-world adherence to National Comprehensive Cancer Network (NCCN) Guidelines regarding PET/CT usage and reported Deuville scores in advanced stage classical Hodgkin lymphoma.
Christopher Yasenchak, MD,...
01/14/2021
Journal of Clinical Pathways
Ovarian Cancer Maintenance: PRIMA, PAOLA-1, VELIA, and Others
ENGAGING EXPERTS
Ovarian Cancer Maintenance: PRIMA, PAOLA-1, VELIA, and Others
06/05/2020
Michael Birrer, MD, PhD, director of the Winthrop P Rockefeller Cancer Institute, University of Arkansas for Medical Sciences, discusses the latest PARP inhibitor indications for frontline maintenance in ovarian cancer, as well as the...
Michael Birrer, MD, PhD, director of the Winthrop P Rockefeller Cancer Institute, University of Arkansas for Medical Sciences, discusses the latest PARP inhibitor indications for frontline maintenance in ovarian cancer, as well as the...
Michael Birrer, MD, PhD,...
06/05/2020
Journal of Clinical Pathways
Multiple Treatment Guideline Updates Released for Lung Cancer
Guideline Updates
Multiple Treatment Guideline Updates Released for Lung Cancer
05/19/2020
The National Comprehensive Cancer Network (NCCN) and the International Association for the Study of Lung Cancer (IASLC) released an updated treatment guideline for non-small cell lung cancer (NSCLC) and treatment...
The National Comprehensive Cancer Network (NCCN) and the International Association for the Study of Lung Cancer (IASLC) released an updated treatment guideline for non-small cell lung cancer (NSCLC) and treatment...
The...
05/19/2020
Journal of Clinical Pathways
News
Genetic Testing Underutilized in Women With History of Ovarian Cancer
08/22/2017
JCP Editors
Less than 20% of patients with a history of ovarian cancer meeting National Comprehensive Cancer Network (NCCN) guidelines have undergone genetic testing or have discussed testing with their health care...
Less than 20% of patients with a history of ovarian cancer meeting National Comprehensive Cancer Network (NCCN) guidelines have undergone genetic testing or have discussed testing with their health care...
Less...
08/22/2017
Journal of Clinical Pathways
Research in Review
Benefits and Shortcomings of Oncology Value Frameworks for Payers
08/03/2017
JCP Editors
Multiple areas have been identified where oncology value frameworks can be revised in order to increase their utility to payers, according to a study in the Journal of Managed Care & Specialty Pharmacy (June...
Multiple areas have been identified where oncology value frameworks can be revised in order to increase their utility to payers, according to a study in the Journal of Managed Care & Specialty Pharmacy (June...
...
08/03/2017
Journal of Clinical Pathways
Research in Review
CML Treatment Decisions Should Factor in Cardiovascular Disease Risk
07/27/2017
JCP Editors
Cardiovascular disease rates and its associated risks are increased in patients with chronic myelogenous leukemia (CML) treated by community-based oncologists and should impact treatment decisions, according to a...
Cardiovascular disease rates and its associated risks are increased in patients with chronic myelogenous leukemia (CML) treated by community-based oncologists and should impact treatment decisions, according to a...
...
07/27/2017
Journal of Clinical Pathways
Clinical Pathways for Advance Stage Gastric Cancer: Standardizing Practice to Decrease Variability and Improve Outcomes
06/13/2017
EXECUTIVE SUMMARY Gastric cancer is the fifth most diagnosed cancer worldwide and the third leading cause of cancer deaths. In the United States and other countries with low rates of gastric cancer, the population...
EXECUTIVE SUMMARY Gastric cancer is the fifth most diagnosed cancer worldwide and the third leading cause of cancer deaths. In the United States and other countries with low rates of gastric cancer, the population...
...
06/13/2017
Journal of Clinical Pathways
Research in Review
Prostate Cancer Testing Guidelines Omit Critical Genetic Features
06/13/2017
JCP Editors
Current National Comprehensive Cancer Network (NCCN) guidelines and Gleason scores cannot reliably stratify patients with risk of prostate cancer for the presence or absence of pathogenic germline variants,...
Current National Comprehensive Cancer Network (NCCN) guidelines and Gleason scores cannot reliably stratify patients with risk of prostate cancer for the presence or absence of pathogenic germline variants,...
...
06/13/2017
Journal of Clinical Pathways

Upcoming Events

February 2 ⁠–⁠ February 5
Western AF Symposium
February 27 ⁠–⁠ March 1
DCLF
March 17 ⁠–⁠ March 19
NP Institute
March 27 ⁠–⁠ March 30
TCIV
March 31 ⁠–⁠ April 2
Rx summit logo
April 21 ⁠–⁠ April 24
SAWC Spring
April 30 ⁠–⁠ May 4
Symposium on Advanced Wound Care
April 30 ⁠–⁠ May 5
WoundCon
May 1 ⁠–⁠ May 3
Senior Living Executive Conference
May 19 ⁠–⁠ May 21
See Full Calendar

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use